By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Adare Pharmaceuticals (Formerly known as Aptalis Pharmatech) 

Princeton Pike Corporate Center
1200 Lenox Drive, Suite 100
Lawrenceville  New Jersey  08648  U.S.A.
Phone: 609-450-1312, Ext 4177 Fax: n/a


SEARCH JOBS

Adare Pharmaceuticals provides enhanced medicines, creating new possibilities for improved patient health. We have expertise in overcoming complex formulation challenges and extending or creating IP protection—resulting in medicines that deliver greater value to all stakeholders, while meeting the needs of patients. We have the ability to transform drug formulations using our proprietary technologies, developing novel Rx and OTC products. Adare is uniquely suited to unlock the potential of more medicines, helping patients to maximize the benefit of their treatments. We are committed to partnering with innovators in the pharmaceutical industry. Visit www.AdarePharma.com and experience a partnership that's truly transformative.


Key Statistics


Email: Marketing@adarepharma.com
Ownership: Private

Web Site: Adare Pharma
Employees: 1,000
Symbol: 
 



Industry
Pharmaceutical






Company News
Adare Pharma Appoints Joseph Del Buono As Vice President, Finance And Chief Financial Officer 8/27/2015 9:28:03 AM
Adare Pharma Appoints Joseph Del Buono As Vice President, Finance And Chief Financial Officer 8/27/2015 9:28:03 AM
Adare Pharma Appoints Joseph Del Buono As Vice President, Finance And Chief Financial Officer 8/26/2015 10:15:52 AM
TPG Completes Acquisition of Aptalis Pharmaceutical Technologies (FRX), Company Renamed Adare Pharmaceuticals 4/2/2015 10:43:25 AM
Aptalis Pharmaceutical Technologies (FRX) Release: Allegra Dry Syrup 5% Launches In Japan 2/20/2015 2:02:37 PM
Forest Laboratories, Inc. (FRX) Sets $1.8 Billion High Yield Bond Deal To Back Aptalis Pharmaceutical Technologies Buy 1/28/2014 7:48:18 AM
Forest Laboratories, Inc. (FRX) Scoops Up Aptalis Pharmaceutical Technologies For $2.9 Billion Cash 1/8/2014 7:29:53 AM
Bridgewater-Based Aptalis Pharmaceutical Technologies Files To Raise $500 Million In IPO 12/27/2013 6:38:49 AM
Novamedica Signs Distribution Agreement With Aptalis Pharmaceutical Technologies To Develop And Commercialize Gastrointestinal Pharmaceutical Products In Russia 12/5/2013 10:00:00 AM
Specialty Drugmaker Aptalis Pharmaceutical Technologies Carries a Hefty $3 Billion Price Tag, Any Takers? 8/7/2013 5:23:00 PM
123456
//-->